| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |